PROCESS FOR FORMULATING A SOLID ORAL DOSAGE FORM OF LOPERAMIDE COMPOUNDS - Patent 0542879

(19)

(11)

EP 0 542 879 A1

(12)

(43)	Date of publication:
	26.05.1993 Bulletin 1993/21

(21)	Application number: 91915390.0

(22)	Date of filing: 29.07.1991

(51)

International Patent Classification (IPC):

A61K 9/ 14^{( . )}
A61K 31/ 445^{( . )}
A61P 1/ 12^{( . )}

A61K 9/ 20^{( . )}
A61K 31/ 505^{( . )}

(86)	International application number:
	PCT/US1991/005291

(87)	International publication number:
	WO 1992/002223 (20.02.1992 Gazette 1992/05)

(84)	Designated Contracting States:
	AT BE CH DE DK ES FR GB GR IT LI LU NL SE

(30)

Priority:

09.08.1990 US 19900565010

(71)	Applicant: THE PROCTER & GAMBLE COMPANY
	Cincinnati, Ohio 45202 (US)

(72)	Inventors:
	BARONE, Daniel, Louis Cincinnati, OH 45238 (US) CHAPURA, Francis, Bernard Hamilton, OH 45011 (US) DENNY, Shawn, Alan Cincinnati, OH 45215 (US)

(74)	Representative: Brooks, Maxim Courtney
	Procter & Gamble Limited Whitley Road Longbenton Newcastle-upon-Tyne NE12 9TS Newcastle-upon-Tyne NE12 9TS (GB)

(54)	PROCESS FOR FORMULATING A SOLID ORAL DOSAGE FORM OF LOPERAMIDE COMPOUNDS